GP suspended for enrolling patients in drug trials without consentBMJ 2003; 326 doi: http://dx.doi.org/10.1136/bmj.326.7384.304/a (Published 08 February 2003) Cite this as: BMJ 2003;326:304
- Owen Dyer
A Hertfordshire GP who included his patients in drug trials without their knowledge was last week suspended by the General Medical Council.
Dr Robert Macindoe Adams, 58, admitted enrolling 12 patients in seven drug trials for pharmaceutical companies including AstraZeneca and SmithKline Beecham without providing an opportunity for informed consent.
The trials involved drugs for depression and hypertension. In two cases Dr Adams was found to have overstated the patients' symptoms to meet the strict criteria for antidepressant trials. He was also found to have changed patients' treatment and prescribed …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial